Search results
NASDAQ Global Market
- On what stock exchange are Editas’ shares traded, what is the ticker symbol, and when did Editas go public? Our common stock is traded on the NASDAQ Global Market under the ticker EDIT. Our initial public offering took place on February 3, 2016.
ir.editasmedicine.com › investor-faqs
Find the latest Editas Medicine, Inc. (EDIT) stock quote, history, news and other vital information to help you with your stock trading and investing.
- Historical Data
Discover historical prices for EDIT stock on Yahoo Finance....
- Holders
Find out the direct holders, institutional holders and...
- Conversations
Find the latest Editas Medicine, Inc. (EDIT) stock...
- Chart
Interactive Chart for Editas Medicine, Inc. (EDIT), analyze...
- Financials
Get the detailed quarterly/annual income statement for...
- Options
View the basic EDIT option chain and compare options of...
- Statistics
Editas Medicine, Inc. (EDIT) Follow. Compare. 5.54 +0.07 ......
- Analysis
See Editas Medicine, Inc. (EDIT) stock analyst estimates,...
- Profile
See the company profile for Editas Medicine, Inc. (EDIT)...
- Historical Data
- 5.96Add to watchlist+0.35 (+6.24%)At close: Tue. Jul 16, 2024 4:00 PM EDT · Nasdaq Real Time Price (USD) · Pre-Market Time
- Open5.70High6.05Low5.67
- Mkt Cap490.14MP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close5.6152 Wk. Low4.4552 Wk. High11.69
Related stocks
People also ask
Is Editas Medicine a publicly traded stock?
Does Editas Medicine (edit) pay a dividend?
Is Editas Medicine a Biotech stock?
Should you buy Editas Medicine (edit)?
- Ratings
- Funding
- Ownership
- Business
- Location
9 Wall Street analysts have issued \"buy,\" \"hold,\" and \"sell\" ratings for Editas Medicine in the last year. There are currently 3 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of \"Buy.\" View Analyst Ratings for Editas Medicine.
(EDIT) raised $100 million in an IPO on Wednesday, February 3rd 2016. The company issued 5,900,000 shares at $16.00-$18.00 per share. Morgan Stanley and J.P. Morgan acted as the underwriters for the IPO and Cowen and Company and JMP Securities were co-managers.
Editas Medicine's stock is owned by a variety of of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.70%), Nikko Asset Management Americas Inc. (1.51%), Sumitomo Mitsui Trust Holdings Inc. (1.47%), Federated Investors Inc. PA (1.23%), Global Thematic Partners LLC (0.97%) and Great Lakes Advisors LLC (0.56%)....
Editas Medicine has a market capitalization of $1.20 billion and generates $31.94 million in revenue each year. The company earns $-109,950,000.00 in net income (profit) each year or ($2.33) on an earnings per share basis. Editas Medicine employs 133 workers across the globe.
Editas Medicine's mailing address is 11 Hurley Street, Cambridge MA, 02141. The company can be reached via phone at 617-401-9000 or via email at mark.mullikin@editasmed.com.
- (617) 401-9000
- 11 Hurley Street, Cambridge MA, 02141
- mark.mullikin@editasmed.com
Get the latest Editas Medicine Inc (EDIT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
5 days ago · Get a real-time Editas Medicine, Inc. (EDIT) stock price quote with breaking news, financials, statistics, charts and more.
- 379.12M
- 69.41M
- 166.13M
- 82.24M
2 days ago · Is Editas Medicine, Inc. a publicly traded stock? Yes, Editas Medicine, Inc. is publicly traded and listed as EDIT on the NASDAQ. It is currently being traded for approximately $5.67.
- Cabaletta Bio, Inc.
- Biotechnology
- 119
- 377.04M
Discover real-time Editas Medicine, Inc. Common Stock (EDIT) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with...
Shares of Editas Medicine (NASDAQ: EDIT) charged sharply higher this week, soaring as much as 41.6%, according to data from S&P Global Market Intelligence.